Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:23:26 EDT Sat 28 Jun 2025
Enter Symbol
or Name
USA
CA



Q:FOLD - AMICUS THERAPEUTICS INC - https://www.amicustherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
FOLD - Q0.25.75·10.150.25.93+0.244.29,952.157,12322,1505.69  5.945  5.64512.65  5.5119:13:21Jun 2515 min RT 2¢

Recent Trades - Last 10 of 22150
Time ETExPriceChangeVolume
19:13:21Q5.790.104
19:13:21Q5.760.07496
17:43:58Q5.750.063
17:41:16Q5.75070.06075
16:39:23Q5.930.2410
16:39:11Q5.930.2410
16:37:22Q5.930.249,606
16:34:44Q5.930.24124
16:29:14Q5.93030.2403133,335
16:27:51Q5.930.24135,288

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-06-25 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Approval of Pombiliti(TM) (cipaglucosidase alfa) + Opfolda(TM) (miglustat) in Japan
2025-06-03 07:00U:FOLDNews ReleaseNew Analysis of Pombiliti(TM) (cipaglucosidase alfa-atga) + Opfolda(TM) (miglustat) Published in Muscle and Nerve
2025-05-30 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in June 2025
2025-05-07 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at the Bank of America 2025 Health Care Conference
2025-05-01 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
2025-04-30 19:13U:FOLDNews ReleaseDimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
2025-04-21 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
2025-02-27 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in March 2025
2025-02-19 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
2025-02-10 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025
2025-02-03 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium(TM) 2025
2025-01-12 16:00U:FOLDNews ReleaseAmicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic Outlook
2025-01-02 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
2024-11-06 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates
2024-11-01 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in November 2024
2024-10-28 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024
2024-10-17 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Settlement of Galafold(TM) (migalastat) Patent Litigation with Teva
2024-10-04 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024
2024-09-03 07:46U:FOLDNews ReleaseUPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
2024-09-03 07:05U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in September 2024